Click for best price
Precision Cancer Tests Market Size, Share 2023
Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Tests. This report contains market size and forecasts of Precision Cancer Tests in global, including the following market information:
Global Precision Cancer Tests Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Precision Cancer Tests market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Imaging Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Precision Cancer Tests include Abbott, BD, Bio-Rad, Cynvenio Biosystems, Foundation Medicine, Genomic Health, Illumina, Myriad Genetics and NanoString Technologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Precision Cancer Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Precision Cancer Tests Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Precision Cancer Tests Market Segment Percentages, by Type, 2022 (%)
Imaging
In Vitro Diagnostic
Others
Global Precision Cancer Tests Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Precision Cancer Tests Market Segment Percentages, by Application, 2022 (%)
Cancer Research Centers
Cancer Hospital
Surgical Centers
Clinics
Others
Global Precision Cancer Tests Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Precision Cancer Tests Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Precision Cancer Tests revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Precision Cancer Tests revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
BD
Bio-Rad
Cynvenio Biosystems
Foundation Medicine
Genomic Health
Illumina
Myriad Genetics
NanoString Technologies
QIAGEN
Randox Laboratories
Roche
Philips
Thermo Fisher Scientific
Outline of Major Chapters:
Chapter 1: Introduces the definition of Precision Cancer Tests, market overview.
Chapter 2: Global Precision Cancer Tests market size in revenue.
Chapter 3: Detailed analysis of Precision Cancer Tests company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Precision Cancer Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Precision Cancer Tests Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Tests Overall Market Size
2.1 Global Precision Cancer Tests Market Size: 2022 VS 2029
2.2 Global Precision Cancer Tests Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Tests Players in Global Market
3.2 Top Global Precision Cancer Tests Companies Ranked by Revenue
3.3 Global Precision Cancer Tests Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Tests Companies in Global Market, by Revenue in 2022
3.5 Global Companies Precision Cancer Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Tests Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Precision Cancer Tests Market Size Markets, 2022 & 2029
4.1.2 Imaging
4.1.3 In Vitro Diagnostic
4.1.4 Others
4.2 By Type - Global Precision Cancer Tests Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Tests Revenue, 2018-2023
4.2.2 By Type - Global Precision Cancer Tests Revenue, 2024-2029
4.2.3 By Type - Global Precision Cancer Tests Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Tests Market Size, 2022 & 2029
5.1.2 Cancer Research Centers
5.1.3 Cancer Hospital
5.1.4 Surgical Centers
5.1.5 Clinics
5.1.6 Others
5.2 By Application - Global Precision Cancer Tests Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Tests Revenue, 2018-2023
5.2.2 By Application - Global Precision Cancer Tests Revenue, 2024-2029
5.2.3 By Application - Global Precision Cancer Tests Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Precision Cancer Tests Market Size, 2022 & 2029
6.2 By Region - Global Precision Cancer Tests Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Tests Revenue, 2018-2023
6.2.2 By Region - Global Precision Cancer Tests Revenue, 2024-2029
6.2.3 By Region - Global Precision Cancer Tests Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Precision Cancer Tests Revenue, 2018-2029
6.3.2 US Precision Cancer Tests Market Size, 2018-2029
6.3.3 Canada Precision Cancer Tests Market Size, 2018-2029
6.3.4 Mexico Precision Cancer Tests Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Tests Revenue, 2018-2029
6.4.2 Germany Precision Cancer Tests Market Size, 2018-2029
6.4.3 France Precision Cancer Tests Market Size, 2018-2029
6.4.4 U.K. Precision Cancer Tests Market Size, 2018-2029
6.4.5 Italy Precision Cancer Tests Market Size, 2018-2029
6.4.6 Russia Precision Cancer Tests Market Size, 2018-2029
6.4.7 Nordic Countries Precision Cancer Tests Market Size, 2018-2029
6.4.8 Benelux Precision Cancer Tests Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Tests Revenue, 2018-2029
6.5.2 China Precision Cancer Tests Market Size, 2018-2029
6.5.3 Japan Precision Cancer Tests Market Size, 2018-2029
6.5.4 South Korea Precision Cancer Tests Market Size, 2018-2029
6.5.5 Southeast Asia Precision Cancer Tests Market Size, 2018-2029
6.5.6 India Precision Cancer Tests Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Precision Cancer Tests Revenue, 2018-2029
6.6.2 Brazil Precision Cancer Tests Market Size, 2018-2029
6.6.3 Argentina Precision Cancer Tests Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Tests Revenue, 2018-2029
6.7.2 Turkey Precision Cancer Tests Market Size, 2018-2029
6.7.3 Israel Precision Cancer Tests Market Size, 2018-2029
6.7.4 Saudi Arabia Precision Cancer Tests Market Size, 2018-2029
6.7.5 UAE Precision Cancer Tests Market Size, 2018-2029
7 Precision Cancer Tests Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Precision Cancer Tests Major Product Offerings
7.1.4 Abbott Precision Cancer Tests Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 BD
7.2.1 BD Company Summary
7.2.2 BD Business Overview
7.2.3 BD Precision Cancer Tests Major Product Offerings
7.2.4 BD Precision Cancer Tests Revenue in Global Market (2018-2023)
7.2.5 BD Key News & Latest Developments
7.3 Bio-Rad
7.3.1 Bio-Rad Company Summary
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Precision Cancer Tests Major Product Offerings
7.3.4 Bio-Rad Precision Cancer Tests Revenue in Global Market (2018-2023)
7.3.5 Bio-Rad Key News & Latest Developments
7.4 Cynvenio Biosystems
7.4.1 Cynvenio Biosystems Company Summary
7.4.2 Cynvenio Biosystems Business Overview
7.4.3 Cynvenio Biosystems Precision Cancer Tests Major Product Offerings
7.4.4 Cynvenio Biosystems Precision Cancer Tests Revenue in Global Market (2018-2023)
7.4.5 Cynvenio Biosystems Key News & Latest Developments
7.5 Foundation Medicine
7.5.1 Foundation Medicine Company Summary
7.5.2 Foundation Medicine Business Overview
7.5.3 Foundation Medicine Precision Cancer Tests Major Product Offerings
7.5.4 Foundation Medicine Precision Cancer Tests Revenue in Global Market (2018-2023)
7.5.5 Foundation Medicine Key News & Latest Developments
7.6 Genomic Health
7.6.1 Genomic Health Company Summary
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Precision Cancer Tests Major Product Offerings
7.6.4 Genomic Health Precision Cancer Tests Revenue in Global Market (2018-2023)
7.6.5 Genomic Health Key News & Latest Developments
7.7 Illumina
7.7.1 Illumina Company Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Precision Cancer Tests Major Product Offerings
7.7.4 Illumina Precision Cancer Tests Revenue in Global Market (2018-2023)
7.7.5 Illumina Key News & Latest Developments
7.8 Myriad Genetics
7.8.1 Myriad Genetics Company Summary
7.8.2 Myriad Genetics Business Overview
7.8.3 Myriad Genetics Precision Cancer Tests Major Product Offerings
7.8.4 Myriad Genetics Precision Cancer Tests Revenue in Global Market (2018-2023)
7.8.5 Myriad Genetics Key News & Latest Developments
7.9 NanoString Technologies
7.9.1 NanoString Technologies Company Summary
7.9.2 NanoString Technologies Business Overview
7.9.3 NanoString Technologies Precision Cancer Tests Major Product Offerings
7.9.4 NanoString Technologies Precision Cancer Tests Revenue in Global Market (2018-2023)
7.9.5 NanoString Technologies Key News & Latest Developments
7.10 QIAGEN
7.10.1 QIAGEN Company Summary
7.10.2 QIAGEN Business Overview
7.10.3 QIAGEN Precision Cancer Tests Major Product Offerings
7.10.4 QIAGEN Precision Cancer Tests Revenue in Global Market (2018-2023)
7.10.5 QIAGEN Key News & Latest Developments
7.11 Randox Laboratories
7.11.1 Randox Laboratories Company Summary
7.11.2 Randox Laboratories Business Overview
7.11.3 Randox Laboratories Precision Cancer Tests Major Product Offerings
7.11.4 Randox Laboratories Precision Cancer Tests Revenue in Global Market (2018-2023)
7.11.5 Randox Laboratories Key News & Latest Developments
7.12 Roche
7.12.1 Roche Company Summary
7.12.2 Roche Business Overview
7.12.3 Roche Precision Cancer Tests Major Product Offerings
7.12.4 Roche Precision Cancer Tests Revenue in Global Market (2018-2023)
7.12.5 Roche Key News & Latest Developments
7.13 Philips
7.13.1 Philips Company Summary
7.13.2 Philips Business Overview
7.13.3 Philips Precision Cancer Tests Major Product Offerings
7.13.4 Philips Precision Cancer Tests Revenue in Global Market (2018-2023)
7.13.5 Philips Key News & Latest Developments
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Company Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Precision Cancer Tests Major Product Offerings
7.14.4 Thermo Fisher Scientific Precision Cancer Tests Revenue in Global Market (2018-2023)
7.14.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Precision Cancer Tests Market Opportunities & Trends in Global Market
Table 2. Precision Cancer Tests Market Drivers in Global Market
Table 3. Precision Cancer Tests Market Restraints in Global Market
Table 4. Key Players of Precision Cancer Tests in Global Market
Table 5. Top Precision Cancer Tests Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Precision Cancer Tests Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Precision Cancer Tests Revenue Share by Companies, 2018-2023
Table 8. Global Companies Precision Cancer Tests Product Type
Table 9. List of Global Tier 1 Precision Cancer Tests Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Tests Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Precision Cancer Tests Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Precision Cancer Tests Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Precision Cancer Tests Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Precision Cancer Tests Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Precision Cancer Tests Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Precision Cancer Tests Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Precision Cancer Tests Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Precision Cancer Tests Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Precision Cancer Tests Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Precision Cancer Tests Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Precision Cancer Tests Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Precision Cancer Tests Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Precision Cancer Tests Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Precision Cancer Tests Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Precision Cancer Tests Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Precision Cancer Tests Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Precision Cancer Tests Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Precision Cancer Tests Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Precision Cancer Tests Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Company Summary
Table 31. Abbott Precision Cancer Tests Product Offerings
Table 32. Abbott Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. BD Company Summary
Table 35. BD Precision Cancer Tests Product Offerings
Table 36. BD Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 37. BD Key News & Latest Developments
Table 38. Bio-Rad Company Summary
Table 39. Bio-Rad Precision Cancer Tests Product Offerings
Table 40. Bio-Rad Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 41. Bio-Rad Key News & Latest Developments
Table 42. Cynvenio Biosystems Company Summary
Table 43. Cynvenio Biosystems Precision Cancer Tests Product Offerings
Table 44. Cynvenio Biosystems Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 45. Cynvenio Biosystems Key News & Latest Developments
Table 46. Foundation Medicine Company Summary
Table 47. Foundation Medicine Precision Cancer Tests Product Offerings
Table 48. Foundation Medicine Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 49. Foundation Medicine Key News & Latest Developments
Table 50. Genomic Health Company Summary
Table 51. Genomic Health Precision Cancer Tests Product Offerings
Table 52. Genomic Health Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 53. Genomic Health Key News & Latest Developments
Table 54. Illumina Company Summary
Table 55. Illumina Precision Cancer Tests Product Offerings
Table 56. Illumina Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 57. Illumina Key News & Latest Developments
Table 58. Myriad Genetics Company Summary
Table 59. Myriad Genetics Precision Cancer Tests Product Offerings
Table 60. Myriad Genetics Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 61. Myriad Genetics Key News & Latest Developments
Table 62. NanoString Technologies Company Summary
Table 63. NanoString Technologies Precision Cancer Tests Product Offerings
Table 64. NanoString Technologies Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 65. NanoString Technologies Key News & Latest Developments
Table 66. QIAGEN Company Summary
Table 67. QIAGEN Precision Cancer Tests Product Offerings
Table 68. QIAGEN Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 69. QIAGEN Key News & Latest Developments
Table 70. Randox Laboratories Company Summary
Table 71. Randox Laboratories Precision Cancer Tests Product Offerings
Table 72. Randox Laboratories Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 73. Randox Laboratories Key News & Latest Developments
Table 74. Roche Company Summary
Table 75. Roche Precision Cancer Tests Product Offerings
Table 76. Roche Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 77. Roche Key News & Latest Developments
Table 78. Philips Company Summary
Table 79. Philips Precision Cancer Tests Product Offerings
Table 80. Philips Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 81. Philips Key News & Latest Developments
Table 82. Thermo Fisher Scientific Company Summary
Table 83. Thermo Fisher Scientific Precision Cancer Tests Product Offerings
Table 84. Thermo Fisher Scientific Precision Cancer Tests Revenue (US$, Mn) & (2018-2023)
Table 85. Thermo Fisher Scientific Key News & Latest Developments
List of Figures
Figure 1. Precision Cancer Tests Segment by Type in 2022
Figure 2. Precision Cancer Tests Segment by Application in 2022
Figure 3. Global Precision Cancer Tests Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Precision Cancer Tests Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Precision Cancer Tests Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Tests Revenue in 2022
Figure 8. By Type - Global Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 9. By Application - Global Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 10. By Type - Global Precision Cancer Tests Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 12. By Application - Global Precision Cancer Tests Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 14. By Region - Global Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 15. By Country - North America Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 16. US Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 20. Germany Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 21. France Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 28. China Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 32. India Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 34. Brazil Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Precision Cancer Tests Revenue Market Share, 2018-2029
Figure 37. Turkey Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Precision Cancer Tests Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BD Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bio-Rad Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cynvenio Biosystems Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Foundation Medicine Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Genomic Health Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Illumina Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Myriad Genetics Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. NanoString Technologies Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. QIAGEN Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Randox Laboratories Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Roche Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Philips Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Thermo Fisher Scientific Precision Cancer Tests Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
